tiprankstipranks
Bolt Biotherapeutics Announces Board Reshuffle and New Appointment
PremiumCompany AnnouncementsBolt Biotherapeutics Announces Board Reshuffle and New Appointment
5M ago
Bolt Biotherapeutics names Brian O’Callaghan chairman
Premium
The Fly
Bolt Biotherapeutics names Brian O’Callaghan chairman
5M ago
Bolt Biotherapeutics reports Q2 EPS (56c), consensus (48c)
Premium
The Fly
Bolt Biotherapeutics reports Q2 EPS (56c), consensus (48c)
6M ago
Bolt Biotherapeutics downgraded to Market Perform from Outperform at Leerink
PremiumThe FlyBolt Biotherapeutics downgraded to Market Perform from Outperform at Leerink
9M ago
Guggenheim downgrades Bolt Biotherapeutics on lead candidate discontinuation
Premium
The Fly
Guggenheim downgrades Bolt Biotherapeutics on lead candidate discontinuation
9M ago
Bolt Biotherapeutics downgraded to Hold from Buy at Stifel
Premium
The Fly
Bolt Biotherapeutics downgraded to Hold from Buy at Stifel
9M ago
Bolt Biotherapeutics enrolls first patient in Phase 2 study of BDC-1001
PremiumThe FlyBolt Biotherapeutics enrolls first patient in Phase 2 study of BDC-1001
1y ago
Bolt Biotherapeutics sees cash funding operations, milestones through 2025
Premium
The Fly
Bolt Biotherapeutics sees cash funding operations, milestones through 2025
1y ago
Bolt Biotherapeutics reports Q3 EPS (43c), consensus (49c)
Premium
The Fly
Bolt Biotherapeutics reports Q3 EPS (43c), consensus (49c)
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100